164 related articles for article (PubMed ID: 16490933)
21. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
22. [A case of necrotizing crescentic glomerulonephritis in which myeloperoxidase antineutrophil cytoplasmic antibodies (ANCA) reflect the disease activity and recognize various neutrophil cytoplasmic constituents].
Fujimoto T; Kimura A; Ameno M; Shiiki H; Dohi K
Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):172-7. PubMed ID: 9134836
[TBL] [Abstract][Full Text] [Related]
23. Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis.
Boomsma MM; Stegeman CA; Oost-Kort WW; Kallenberg CG; Moguilevsky N; Limburg PC; Tervaert JW
J Immunol Methods; 2001 Aug; 254(1-2):47-58. PubMed ID: 11406152
[TBL] [Abstract][Full Text] [Related]
24. FcγRIIB regulates T-cell autoreactivity, ANCA production, and neutrophil activation to suppress anti-myeloperoxidase glomerulonephritis.
Ooi JD; Gan PY; Chen T; Eggenhuizen PJ; Chang J; Alikhan MA; Odobasic D; Holdsworth SR; Kitching AR
Kidney Int; 2014 Dec; 86(6):1140-9. PubMed ID: 24869670
[TBL] [Abstract][Full Text] [Related]
25. The role of myeloperoxidase and myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis.
Arimura Y; Kawashima S; Yoshihara K; Komagata Y; Kaname S; Yamada A
Clin Exp Nephrol; 2013 Oct; 17(5):634-637. PubMed ID: 23504409
[TBL] [Abstract][Full Text] [Related]
26. Impact of MPO-ANCA-mediated oxidative imbalance on renal vasculitis.
Hilhorst M; Maria AT; Kavian N; Batteux F; Borderie D; Le Quellec A; van Paassen P; Guilpain P
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1769-F1776. PubMed ID: 30207165
[TBL] [Abstract][Full Text] [Related]
27. Expression of macrophage migration inhibitory factor in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Taniguchi Y; Yorioka N; Yamashita K; Masaki T; Yamakido M
Clin Nephrol; 2000 Aug; 54(2):147-50. PubMed ID: 10968692
[TBL] [Abstract][Full Text] [Related]
28. [Case of immune complex crescentic glomerulonephritis with consistently high titers of MPO-ANCA for 6 years].
Ayada M; Matsuo T; Takada S; Kusaura T; Suda S; Okado T; Mori Y; Tajima M; Kuwahara M; Kobayashi Y; Tsukamoto Y; Sasaki S
Nihon Jinzo Gakkai Shi; 2007; 49(5):511-6. PubMed ID: 17695814
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
Schreiber A; Xiao H; Falk RJ; Jennette JC
J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
Okano K; Yumura W; Nitta K; Honda K; Uchida K; Nihei H
Clin Nephrol; 2001 Apr; 55(4):275-81. PubMed ID: 11334312
[TBL] [Abstract][Full Text] [Related]
31. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.
Xiao H; Schreiber A; Heeringa P; Falk RJ; Jennette JC
Am J Pathol; 2007 Jan; 170(1):52-64. PubMed ID: 17200182
[TBL] [Abstract][Full Text] [Related]
32. [MPO-positive cells and extracellular MPO in the glomeruli of MPO-ANCA-associated glomerulonephritis].
Kawashima S; Arimura Y; Nakabayashi K; Yamada A
Nihon Jinzo Gakkai Shi; 2009; 51(1):56-67. PubMed ID: 19238910
[TBL] [Abstract][Full Text] [Related]
33. Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
Hamano Y; Ito F; Suzuki O; Koura M; Matsuoka S; Kobayashi T; Sugitani Y; Wali N; Koyanagi A; Hino O; Suzuki S; Sugamata R; Yoshizawa H; Yumura W; Maruyama N; Kameoka Y; Noda Y; Hasegawa Y; Arai T; Suzuki K
Autoimmunity; 2019; 52(5-6):208-219. PubMed ID: 31476889
[TBL] [Abstract][Full Text] [Related]
34. Renal neutrophils infiltration in antineutrophil cytoplasmic antibodies-negative pauci-immune crescentic glomerulonephritis.
Xing GQ; Chen M; Liu G; Wang SX; Zhao MH
Am J Med Sci; 2010 Dec; 340(6):474-80. PubMed ID: 21119331
[TBL] [Abstract][Full Text] [Related]
35. [MPO-ANCA positive rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with D-penicillamine].
Nanke Y; Akama H; Terai C; Hara M; Kamatani N
Nihon Rinsho Meneki Gakkai Kaishi; 1999 Oct; 22(5):354-9. PubMed ID: 10616290
[TBL] [Abstract][Full Text] [Related]
36. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
[TBL] [Abstract][Full Text] [Related]
37. The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis.
Ooi JD; Chang J; Hickey MJ; Borza DB; Fugger L; Holdsworth SR; Kitching AR
Proc Natl Acad Sci U S A; 2012 Sep; 109(39):E2615-24. PubMed ID: 22955884
[TBL] [Abstract][Full Text] [Related]
38. IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis.
van Timmeren MM; van der Veen BS; Stegeman CA; Petersen AH; Hellmark T; Collin M; Heeringa P
J Am Soc Nephrol; 2010 Jul; 21(7):1103-14. PubMed ID: 20448018
[TBL] [Abstract][Full Text] [Related]
39. [A case of MPO-ANCA-related nephritis caused by an anti-tuberculosis drug].
Tanaka H; Oshiro Y; Kawanaka N; Kawasaki F; Okimotoi N
Nihon Jinzo Gakkai Shi; 2013; 55(2):172-6. PubMed ID: 23631305
[TBL] [Abstract][Full Text] [Related]
40. Serum myeloperoxidase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis.
Arimura Y; Minoshima S; Kamiya Y; Tanaka U; Nakabayashi K; Kitamoto K; Nagasawa T; Sasaki T; Suzuki K
Clin Nephrol; 1993 Nov; 40(5):256-64. PubMed ID: 8281714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
